PubMed · 7633787
Implants for spasticity.
Abstract
In carefully selected groups of patients, intrathecal baclofen therapy offers well-proven benefits in reducing spasticity, notably in cases of spinal injury and multiple sclerosis. The initial costs of implantation are high, and there must be a long-term commitment by both patient and medical personnel to careful and proper management. Nevertheless, in suitable cases, the techniques should generally be properly considered before proceeding to any irreversible destructive neurosurgical procedure.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
P J Teddy. 1995. Implants for spasticity.. https://pubmed.ncbi.nlm.nih.gov/7633787/
Cite the original work for its findings. Save a collection to share your selection of sources.